MétaCan
Menu
Back to cohort
Record W4414452576 · doi:10.1136/bmjopen-2025-105459

Randomised controlled study investigating standard dose continuous renal replacement therapy (CRRT) versus low-dose CRRT in critically ill patients with acute kidney injury (AKI): study protocol for a prospective, randomised, controlled, international, multicentre trial (the ‘Ketzerei’ trial)

2025· article· en· W4414452576 on OpenAlexaff
Christian Strauß, Mahan Sadjadi, Thilo von Groote, Hendrik Booke, Ludwig Maximilian Schöne, Clara Hegner, Carola Wempe, Melanie Meersch, Joachim Gerß, Alice Bernard, Helene A. Haeberle, Peter Rosenberger, Tim Rahmel, Matthias Unterberg, Michael Adamzik, Christian Arndt, Hinnerk Wulf, Stefano Romagnoli, Manuela Bonizzoli, Raffaele Mandarano, Vedran Premužić, Lúcia Andrade, Igor Smolentzov, Sean M. Bagshaw, Lakhmir S. Chawla, Alexander Zarbock

Bibliographic record

VenueBMJ Open · 2025
Typearticle
Languageen
FieldMedicine
TopicAcute Kidney Injury Research
Canadian institutionsUniversity of Alberta
Fundersnot available
KeywordsAcute kidney injuryRenal replacement therapyCritically illProtocol (science)Kidney diseaseMEDLINE

Abstract

fetched live from OpenAlex

INTRODUCTION: The only supportive therapy for patients with severe acute kidney injury (AKI), a common complication among the critically ill, is dialysis. Based on the literature and current guidelines, continuous renal replacement therapy (CRRT) with a total effluent dose of 20-25 mL/kg/hour and adjustments to ensure such dose is delivered despite down time (eg, due to surgical procedures) is recommended. However, experimental and clinical studies suggest that azotaemia, which can be induced by lowering the effluent dose, may accelerate renal recovery. This clinical study investigates whether a lower effluent dose (10-15 mL/kg/hour) for a maximum of 7 days or until successful (>24 hours) liberation of CRRT in critically ill patients with a dialysis-dependent AKI accelerates renal recovery and reduces time on CRRT compared with guideline-directed standard dose (25-30 mL/kg/hour). METHODS AND ANALYSIS: The Ketzerei trial is an international, multicentre randomised, controlled trial, designed to investigate if a lower effluent dose (10-15 mL/kg/hour) accelerates renal recovery and reduces the time on CRRT compared with the guideline directed standard effluent dose (25-30 mL/kg/hour). The study aims to enrol 150 critically ill patients with a dialysis-dependent AKI. Eligible patients will be randomised to receive either a standard effluent dose (control group, 25-30 mL/kg/hour) or lower effluent dose (interventional group, 10-15 mL/kg/hour). The primary endpoint is the number of days free from CRRT and alive (from randomisation through day 28). Key secondary endpoints include the number of (serious) adverse events due to potential uremia, the duration of RRT and intensive care unit survival. ETHICS AND DISSEMINATION: The Ketzerei trial has been approved by the Ethics Committee of the Chamber of Physicians Westfalen-Lippe (2023-343 f-s), the University of Muenster and subsequently by the corresponding Ethics Committee of the participating sites. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and will guide patient care and further research. TRIAL REGISTRATION NUMBER: clinicaltrials.gov (NCT06021288).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.014
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.033
Threshold uncertainty score0.109

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0150.014
Meta-epidemiology (narrow)0.0050.002
Meta-epidemiology (broad)0.0120.005
Bibliometrics0.0010.002
Science and technology studies0.0010.004
Scholarly communication0.0030.003
Open science0.0030.001
Research integrity0.0060.004
Insufficient payload (model declined to judge)0.0330.005

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.052
GPT teacher head0.453
Teacher spread0.401 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueBMJ OpenSame topicAcute Kidney Injury ResearchFrench-language works237,207